Review



spot-level pcw6.5 fh6_1000l2_cn74_d1 spatial transcriptomics slide  (Spatial Transcriptomics Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Spatial Transcriptomics Inc spot-level pcw6.5 fh6_1000l2_cn74_d1 spatial transcriptomics slide
    Spot Level Pcw6.5 Fh6 1000l2 Cn74 D1 Spatial Transcriptomics Slide, supplied by Spatial Transcriptomics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/spot+level+transcriptomes/spot+level+pcw6+5+fh6+1000l2+cn74+d1+spatial+transcriptomics+slide/pm35753702-394-17-20
    Average 90 stars, based on 1 article reviews
    spot-level pcw6.5 fh6_1000l2_cn74_d1 spatial transcriptomics slide - by Bioz Stars, 2026-10
    90/100 stars

    Images

    Related Articles

    other:

    Article Title: A comprehensive comparison on cell-type composition inference for spatial transcriptomics data.
    Article Snippet: For human heart Spatial Transcriptomics ST data, we chose the FH6_1000L2_CN74_D1 slide.

    Article Title: A comprehensive comparison on cell-type composition inference for spatial transcriptomics data.
    Article Snippet: For the developing human heart tissue, we select the single-cell level PCW6.5_1 ISS data to match the spot-level PCW6.5 FH6_1000L2_CN74_D1 Spatial Transcriptomics slide [31].



    Similar Products

    86
    Spatial Transcriptomics Inc spot level transcriptomes
    Spot Level Transcriptomes, supplied by Spatial Transcriptomics Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/spot+level+transcriptomes/level+spot+transcriptomes/pm41431371-86-8-12
    Average 86 stars, based on 1 article reviews
    spot level transcriptomes - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    86
    Spatial Transcriptomics Inc spot level spatial transcriptomics
    | a , Conceptual framework: cell–cell communication is inferred based on spatial proximity, where ligand-expressing (sender) cells are more likely to interact with nearby receptor-expressing (receiver) cells. b , Tissue samples are collected and processed using spatial <t>transcriptomics</t> (e.g., Xenium). c , Spatial gene expression images are generated, with cell type annotations (top) and receptor–ligand pairs curated from public databases (e.g., CellChat, CellPhoneDB, SpaTalk) or custom lists (bottom). d , Communication is modeled across various scenarios: non-interacting dispersed states, gain of receptor expression, gain of ligand expression, or recurring local interactions. A multicellular communication interaction module (MCIM) is defined as a set of co-localized receptor–ligand interactions. e , Spatial transcriptomics data with annotated cell types visualized by color. f , Communication edges are inferred by identifying ligand-expressing and receptor-expressing cells using TACIT and then connecting cells within a 50µm spatial radius. g , The tissue is partitioned into spatial bins; receptor–ligand edges are counted per bin. h , Kernel density estimation generates a spatial map of communication density for each receptor–ligand pair. i , Communication densities are summarized in a matrix (bins × receptor–ligand pairs), where values represent interaction densities. j , This matrix is clustered to identify MCIMs. k , Heatmap of communication densities for each MCIM. l , MCIMs are grouped by signaling pathway and mapped onto spatial tissue architecture. m–n , MCIMs can be associated with clinical outcomes, such as survival, and may serve as biomarkers or therapeutic targets (e.g., in GVHD).
    Spot Level Spatial Transcriptomics, supplied by Spatial Transcriptomics Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/spot+level+transcriptomes/spatial+spots+transcriptomics/bio_rxiv__2025__08__07__669133-24-15-16
    Average 86 stars, based on 1 article reviews
    spot level spatial transcriptomics - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    90
    Spatial Transcriptomics Inc spot-level pcw6.5 fh6_1000l2_cn74_d1 spatial transcriptomics slide
    | a , Conceptual framework: cell–cell communication is inferred based on spatial proximity, where ligand-expressing (sender) cells are more likely to interact with nearby receptor-expressing (receiver) cells. b , Tissue samples are collected and processed using spatial <t>transcriptomics</t> (e.g., Xenium). c , Spatial gene expression images are generated, with cell type annotations (top) and receptor–ligand pairs curated from public databases (e.g., CellChat, CellPhoneDB, SpaTalk) or custom lists (bottom). d , Communication is modeled across various scenarios: non-interacting dispersed states, gain of receptor expression, gain of ligand expression, or recurring local interactions. A multicellular communication interaction module (MCIM) is defined as a set of co-localized receptor–ligand interactions. e , Spatial transcriptomics data with annotated cell types visualized by color. f , Communication edges are inferred by identifying ligand-expressing and receptor-expressing cells using TACIT and then connecting cells within a 50µm spatial radius. g , The tissue is partitioned into spatial bins; receptor–ligand edges are counted per bin. h , Kernel density estimation generates a spatial map of communication density for each receptor–ligand pair. i , Communication densities are summarized in a matrix (bins × receptor–ligand pairs), where values represent interaction densities. j , This matrix is clustered to identify MCIMs. k , Heatmap of communication densities for each MCIM. l , MCIMs are grouped by signaling pathway and mapped onto spatial tissue architecture. m–n , MCIMs can be associated with clinical outcomes, such as survival, and may serve as biomarkers or therapeutic targets (e.g., in GVHD).
    Spot Level Pcw6.5 Fh6 1000l2 Cn74 D1 Spatial Transcriptomics Slide, supplied by Spatial Transcriptomics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/spot+level+transcriptomes/spot+level+pcw6+5+fh6+1000l2+cn74+d1+spatial+transcriptomics+slide/pm35753702-394-17-20
    Average 90 stars, based on 1 article reviews
    spot-level pcw6.5 fh6_1000l2_cn74_d1 spatial transcriptomics slide - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    Image Search Results


    | a , Conceptual framework: cell–cell communication is inferred based on spatial proximity, where ligand-expressing (sender) cells are more likely to interact with nearby receptor-expressing (receiver) cells. b , Tissue samples are collected and processed using spatial transcriptomics (e.g., Xenium). c , Spatial gene expression images are generated, with cell type annotations (top) and receptor–ligand pairs curated from public databases (e.g., CellChat, CellPhoneDB, SpaTalk) or custom lists (bottom). d , Communication is modeled across various scenarios: non-interacting dispersed states, gain of receptor expression, gain of ligand expression, or recurring local interactions. A multicellular communication interaction module (MCIM) is defined as a set of co-localized receptor–ligand interactions. e , Spatial transcriptomics data with annotated cell types visualized by color. f , Communication edges are inferred by identifying ligand-expressing and receptor-expressing cells using TACIT and then connecting cells within a 50µm spatial radius. g , The tissue is partitioned into spatial bins; receptor–ligand edges are counted per bin. h , Kernel density estimation generates a spatial map of communication density for each receptor–ligand pair. i , Communication densities are summarized in a matrix (bins × receptor–ligand pairs), where values represent interaction densities. j , This matrix is clustered to identify MCIMs. k , Heatmap of communication densities for each MCIM. l , MCIMs are grouped by signaling pathway and mapped onto spatial tissue architecture. m–n , MCIMs can be associated with clinical outcomes, such as survival, and may serve as biomarkers or therapeutic targets (e.g., in GVHD).

    Journal: bioRxiv

    Article Title: STARComm Scalably Detects Emergent Modules of Spatial Cell-Cell Communication in Inflammation and Cancer

    doi: 10.1101/2025.08.07.669133

    Figure Lengend Snippet: | a , Conceptual framework: cell–cell communication is inferred based on spatial proximity, where ligand-expressing (sender) cells are more likely to interact with nearby receptor-expressing (receiver) cells. b , Tissue samples are collected and processed using spatial transcriptomics (e.g., Xenium). c , Spatial gene expression images are generated, with cell type annotations (top) and receptor–ligand pairs curated from public databases (e.g., CellChat, CellPhoneDB, SpaTalk) or custom lists (bottom). d , Communication is modeled across various scenarios: non-interacting dispersed states, gain of receptor expression, gain of ligand expression, or recurring local interactions. A multicellular communication interaction module (MCIM) is defined as a set of co-localized receptor–ligand interactions. e , Spatial transcriptomics data with annotated cell types visualized by color. f , Communication edges are inferred by identifying ligand-expressing and receptor-expressing cells using TACIT and then connecting cells within a 50µm spatial radius. g , The tissue is partitioned into spatial bins; receptor–ligand edges are counted per bin. h , Kernel density estimation generates a spatial map of communication density for each receptor–ligand pair. i , Communication densities are summarized in a matrix (bins × receptor–ligand pairs), where values represent interaction densities. j , This matrix is clustered to identify MCIMs. k , Heatmap of communication densities for each MCIM. l , MCIMs are grouped by signaling pathway and mapped onto spatial tissue architecture. m–n , MCIMs can be associated with clinical outcomes, such as survival, and may serve as biomarkers or therapeutic targets (e.g., in GVHD).

    Article Snippet: However, a fundamental challenge arises because most of these tools were designed for two-dimensional and spot-level spatial transcriptomics .

    Techniques: Expressing, Gene Expression, Generated, Biomarker Discovery

    a , Overview of chronic GVHD manifestations across organ systems in the patient cohort. Percentages indicate the frequency of organ involvement across individuals. b , Cohort composition showing 43 minor salivary gland samples collected from 23 patients, including both healthy controls and GVHD cases. c , Spatial transcriptomics was performed using the Xenium platform on minor salivary gland tissue microarrays (TMAs), enabling single-cell resolution mapping of gene expression. d , Integration of receptor–ligand spatial networks across tissues identified MCIMs based on recurrent cellular interaction patterns (top). These MCIMs were annotated using KEGG and GO enrichment and evaluated for therapeutic relevance using the newly developed spatial Drug2Cell pipeline (bottom). e–f , UMAP visualization of bin-level communication densities across all tissues, colored by GVHD status and MCIM membership. g , Heatmap showing receptor–ligand density within each MCIM, highlighting signaling pathways associated with disease. h , Proportion plot illustrating the distribution of specific MCIMs across 36 tissue samples. i , Heatmap depicting enrichment scores of the top interacting cell types within each MCIM.

    Journal: bioRxiv

    Article Title: STARComm Scalably Detects Emergent Modules of Spatial Cell-Cell Communication in Inflammation and Cancer

    doi: 10.1101/2025.08.07.669133

    Figure Lengend Snippet: a , Overview of chronic GVHD manifestations across organ systems in the patient cohort. Percentages indicate the frequency of organ involvement across individuals. b , Cohort composition showing 43 minor salivary gland samples collected from 23 patients, including both healthy controls and GVHD cases. c , Spatial transcriptomics was performed using the Xenium platform on minor salivary gland tissue microarrays (TMAs), enabling single-cell resolution mapping of gene expression. d , Integration of receptor–ligand spatial networks across tissues identified MCIMs based on recurrent cellular interaction patterns (top). These MCIMs were annotated using KEGG and GO enrichment and evaluated for therapeutic relevance using the newly developed spatial Drug2Cell pipeline (bottom). e–f , UMAP visualization of bin-level communication densities across all tissues, colored by GVHD status and MCIM membership. g , Heatmap showing receptor–ligand density within each MCIM, highlighting signaling pathways associated with disease. h , Proportion plot illustrating the distribution of specific MCIMs across 36 tissue samples. i , Heatmap depicting enrichment scores of the top interacting cell types within each MCIM.

    Article Snippet: However, a fundamental challenge arises because most of these tools were designed for two-dimensional and spot-level spatial transcriptomics .

    Techniques: Gene Expression, Protein-Protein interactions